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A guide to performing a peer review of
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Abstract
Peer review of journal articles is an important step in the research process. Editors rely on the expertise of peer
reviewers to properly assess submissions. Yet, peer review quality varies widely and few receive training or guidance
in how to approach the task.
This paper describes some of the main steps that peer reviewers in general and, in particular, those performing
reviewes of randomised controlled trials (RCT), can use when carrying out a review. It can be helpful to begin with
a brief read to acquaint yourself with the study, followed by a detailed read and a careful check for flaws. These
can be divided into ‘major’ (problems that must be resolved before publication can be considered) and ‘minor’
(suggested improvements that are discretionary) flaws. Being aware of the appropriate reporting checklist for the
study being reviewed (such as CONSORT and its extensions for RCTs) can also be valuable.
Competing interests or prejudices might corrode the review, so ensuring transparency about them is important.
Finally, ensuring that the paper’s strengths are acknowledged along with a dissection of the weaknesses provides
balance and perspective to both authors and editors. Helpful reviews are constructive and improve the quality of
the paper. The proper conduct of a peer review is the responsibility of all who accept the role.
Keywords: CONSORT statement, Editorial responsibilities, Medical journal publishing, Peer review,
Randomised controlled trial
Background
Peer review of journal articles is an important process in
research. It is part of the underlying engine that aims to
sort out which papers will be published and what modi-
fications are needed before this occurs.
It is easy to assume that reviewers’ duties and editors’
objectives are identical: we all want to see that good pa-
pers are accepted and flawed ones rejected, and that all
are papers improved by the review process. In a study of
over 200 reviewers of randomised controlled trials
(RCTs) in high impact medical journals, reviewers ranked
activities such as ‘evaluating the risk of bias’, and ‘checking
that the conclusions were consistent with the results’, top
[1]. However, the 171 participating editors ranked these
much lower, instead wanting to simply know whether the
reviewers ‘did or did not recommend publication’ and
‘whether this was an important topic’ [1].
Editors rely on the expertise of their peer reviewers to
provide the necessary background (typically content
and/or methodological) to properly assess submissions.
While there are imperfections in the peer review system
and some doubts about the impact of peer review [2, 3],
it is a system that is used universally. However, the qual-
ity of peer review varies enormously and few reviewers
receive training in how to do it and may not be aware of
some of the elements to consider or when new to
reviewing, how to approach the task. In this paper, we
describe some of the main steps that peer reviewers of
research papers in general, and RCTs in particular, can
use to guide their review.
General steps – for all research articles
Acquaint yourself with the paper
It is a good idea to read the paper soon after your com-
mission to referee it. Leaving it to the last minute risks
introducing a delay if you discover a problem which
means that you cannot complete it (for example, a con-
flict of interest that only emerges after a detailed read or
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addressing an area in which you have no expertise). In
any case, a rapid read allows you to get a fast grasp of
the content to prepare you for the full task. Breaking the
research study into its component parts can help you to
understand the main elements of the study. For those
familiar with doing this step in critical appraisal, the
example component parts for most RCTs would be:
Participants/Patient, Intervention, Comparator, and Out-
comes (or PICO). For studies that are not RCTs, many
of these components are still relevant – for example,
Participants/Problem/Population, Issue/Index (if an obser-
vational study), and Outcomes. Identifying what the study’s
question is can help to initially orient you to the paper and
consider whether the most appropriate study design was
used to answer the question posed by the researchers.
Many journals ask their reviewers to classify remaining
flaws into ‘major’ (defined as requiring satisfactory reso-
lution before publication can be considered) and ‘minor’
(discretionary, suggestions that might improve the paper,
but could be ignored). This is a useful classification sys-
tem to follow anyway, even if not a requirement of the
journal.
Is the quality good enough? Check for major flaws
Among the things that editors have to decide, one of the
most essential is whether a paper is fatally flawed. This
means that, whatever else – even if a fascinating topic,
and beautifully crafted in breathless prose – a critical
problem may mean it cannot be published, even with
complete overhaul. The word ‘fatal’ implies no hope of
resuscitation. Sometimes what appears to be a fatal flaw
may actually be inadequate reporting (for example, not
reporting ethical approval or trial registration), in which
case, stop the review until this is addressed with the
authors of the paper (through the editorial office of
course – never directly with the authors). The Editor/
editorial office may ask the authors to provide more in-
formation to resolve the impasse. Some journals screen
for certain types of fatal flaws before sending papers for
review; others do not. If the issue is not inadequate
reporting and there is truly a fatal flaw, stop. There is
nothing else necessary to comment on. Focus your re-
port on that fatal flaw; however, do mention that you did
not review the remainder of the paper. Your responsibil-
ity as a peer reviewer ends when you describe how it is
not possible to repair this paper. Bear in mind that what
is a ‘fatal’ flaw can be quite subjective and will vary be-
tween journals, editors, and reviewers. What some believe
is fatal, others may see as a major flaw that is reparable in
some way.
Major flaws are serious flaws that must be addressed
before publication can be considered appropriate. Some
examples of major flaws, that are applicable to many
study designs, are provided in Box 1.
Major flaws in RCTs
There are special requirements for the conduct and
reporting of RCTs, and peer reviewers should carefully
check that these requirements have been met. Unfortu-
nately, peer reviewers are not usually good at detecting
these [4]. In one study, a journal asked 607 peer reviewers
to participate and gave them three (previously published)
RCTs which were altered so that, after removing the ori-
ginal authors’ names and any other identifying features,
Box 1 Examples of major flaws that must be
addressed before publication is possible
Major flaws - research papers in general
 Required ethics approval, and participant consent, was not
obtained. This may be considered a fatal flaw by most
journals;
 Methods that are not described sufficiently well to enable
replication of the study;
 Post hoc analyses – that is, analyses that are undertaken after
the data are collected and examined, but were not planned
beforehand (a priori). The danger of doing this is that
interesting analyses might be presented, while uninteresting
ones are not, thereby introducing a bias. If performed, post
hoc analyses should be carefully labelled as such to avoid
confusion, or, only be presented as hypothesis-generating, to
be formally tested in a future study;
 Important and relevant research not cited (especially studies
with results that contradict the study being reviewed);
 Study limitations not adequately acknowledged;
 Conclusions that do not match the results and are not
supported by data.
Major flaws - RCTs
 The trial was not prospectively registered in an appropriate
trial registry, prior to the recruitment of participants. This is
fatal for many (but not all) journals [17], and one alternative
(not as ideal as prospective registration, but better than
non-publication) is to deposit results with an acceptable
registry. Mandating the registration of trials is designed to
reduce bias in the literature that occurs from the differential
publishing of studies with positive (or ‘interesting’) results
rather than negative ones, leaving the literature (as reflected
in systematic reviews, for example) with a positive bias [18].
It also prevents bias from the post hoc analyses of subgroups
discussed in Box 1.
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nine major errors were deliberately added [5]; reviewers
were able to identify a mean of only 2.6 errors. There have
been calls for innovations in providing training to would-
be reviewers of RCTs before they can enter a register of
‘RCT reviewers’ that journals could draw upon [6]. Inter-
ventions to improve the quality of peer review have had
mixed results when evaluated in RCTs [5, 7, 8]. The most
recent trial suggested, although not conclusively, that con-
ducting an additional review based on reporting guidelines
might result in small improvements in paper quality [8].
Critically appraising the RCT to determine its risk of
bias, and where necessary, whether this has been appro-
priately acknowledged, is important. Reviewers who are
less experienced with critical appraisal might find using
the mnemonic RAMbo useful to assess key types of po-
tential bias: Randomised (was there random allocation,
concealed allocation, and baseline similarity of groups?);
Attrition (was there adequate follow-up, intention-to-
treat analysis, and, aside from the experimental interven-
tion, were the groups treated equally?); and Measurement
(was it done by blinded assessors, or were objective mea-
sures used?).
It is good practice to undertake an extra step in
reviewing RCTs, to check either the published protocol,
or its registry entry, to establish whether all measured
outcomes were reported. The statistical analyses of
RCTs sometimes require specialized expertise. If you
are unsure whether the analyses have been performed
or interpreted correctly, do not be afraid to alert the
editor to this and report that a statistical review is
also required. Journals often have statistical reviewers
they can call on, and alerting the Editors to a specific
need may be very helpful.
What else could be improved? Check for minor flaws
Examples of minor flaws include writing that is clumsy;
lack of clarity in some of the argument (usually in the
Background and/or Discussion); minor details missing
or inadequately reported; tables or figures that duplicate
the text or, conversely, are not appropriately referred to;
unclear tables or figures; or referencing errors. Tables
and figures should typically be self-contained. This means
that it should be possible to understand them without ref-
erence to the text.
Sometimes you might want to debate a statement that
you disagree with. Here, we enter a more subjective terri-
tory. Some of your comments may be very helpful – and
authors may well thank the reviewer for the suggestion
(this is common), or refute it with some well-constructed
arguments (just as common!). Nevertheless, it is worth la-
belling your concerns as those suggested improvements
which you think the authors need to take up before publi-
cation, and those which are best left to the discretion of
the authors and editors. Figure 1 provides examples of
‘less helpful’ and ‘more helpful’ reviewer’s comments,
on a number of major and minor flaws, for a hypo-
thetical RCT.
Using reporting guidelines
Where better to find guidelines about which items are es-
sential for each study design than those intended for use by
authors? Reporting guidelines can be used to help inform
peer review [9]. There are reporting guidelines for many of
the major study designs. For example, there are reporting
statements for RCTs, systematic reviews, observational
studies, diagnostic studies, case reports, economic evalua-
tions, and even for protocols of studies. A complete list of
reporting guidelines is maintained by the EQUATOR Net-
work [10].
Reporting guideline checklists follow the flow of the
paper, presenting items in approximately the order encoun-
tered, from the Introduction through to Discussion (Fig. 2).
Many, but not all journals require that authors provide a
completed checklist for a submitted paper, indicating where
each checklist item has been addressed. Some journals as-
sess the checklist in the editorial office, others expect re-
viewers to. It is good practice for reviewers to examine the
checklist, if provided, to ensure that all items have been ad-
equately addressed. As well as being familiar with the
checklist items, reviewers who are not familiar with the
relevant reporting guideline may find it helpful to read
the full explanation and elaboration paper that
accompanies the reporting guideline to understand the ra-
tionale for each item and see examples of ‘good’ reporting.
Noting reporting guideline items that have not been
reported, or not reported well, should be included in your
review. You might detect a major flaw, such as inappropriate
statistical analyses or something that has increased the
study’s risk of bias but has not been appropriately explained
or accounted for in the limitations and interpretations of the
results. However, not adhering to a reporting item does not
necessarily constitute a major flaw: missing information
might simply reflect the author not reporting specific or
enough information in the paper, something which might be
easily resolved at the revision stage, and so might be more
appropriate to classify as a minor flaw.
The journal that you are reviewing for might also have
specific requirements. For example, the BMJ now requires a
statement about patient involvement in setting the research
question, and the design, implementation, and dissemin-
ation of the research [11]. These additional requirements
will typically be communicated to you when the paper is
sent to you for review.
Reporting guidelines for RCTs
The CONsolidated Standards of Reporting Trials (CON-
SORT) Statement has been available for many years now
(Checklist in Fig. 1). Over the years, a number of CONSORT
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extension statements have been developed [12]. Whether to
use the main CONSORT statement or an extension depends
on the RCT that you are reviewing. Some extensions are
specific to the design of the RCT – for example, there is an
extension for cluster RCTs [13] and one for pragmatic RCTs
[14]. Others are specific to the type of data that were col-
lected, such as the extension for reporting harms outcomes
[15]. Other extensions are generic and are intended to be
used with most RCTs, regardless of the design or data –
for example, the Template for Intervention Description
and Replication (TIDieR) guide, is an extension to item 5
of CONSORT and provides guidance for how to describe
the intervention that was evaluated [16]. Familiarizing
yourself with the CONSORT statement and its various
extensions so that you know which to use during
peer review is a good idea.
Final thoughts
Dealing with your own biases, prejudices, and conflicts of
interest
Sometimes you will be asked to comment on a paper
that is antithetical to your point of view. It is important
that your own position does not make you overly crit-
ical – and similarly, papers that exactly reinforce your
approach should not receive a less critical review. For
many journals, you will be asked to complete a declaration
of Conflict of Interest (also called, perhaps more accur-
ately, a ‘Competing Interests’) form. You can list your prej-
udices here among the usual questions about whether you
have financial or non-financial interests that might be
advantaged or disadvantaged by publication of the paper.
This will enable the Editor to evaluate your comments
appropriately.
Be nice
While the rejection of a paper can be demoralizing, all
authors experience it at some stage and constructive
reviews improve papers. Because publication in quality
journals can influence careers in a very competitive
world, rejection can exact a heavy toll. Reviewers have a
responsibility to deliver criticisms carefully and con-
structively. There is usually something good about every
paper that you can find to comment on. Making some
positive and constructive comments to go with the
Fig. 1 Examples of ‘less helpful’ and ‘more helpful’ peer review comments on a hypothetical RCT paper
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Fig. 2 The CONSORT (CONsolidated Standards Of Reporting Trials) checklist, available at http://www.consort-statement.org/
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disagreeable ones about aspects of the paper that need
to be improved can help to keep your review balanced.
Of course, positive comments must not be overdone in
poor quality papers – this can create problems for the
Editors if the Authors subsequently appeal: “How can
you reject my paper when…”, or even “Why should I
revise it? ……the reviewers thought it was fine!”
Confidentiality and fully disclosed comments
Different journals have widely different policies. The usual
system allows your comments, which are written anonym-
ously, to be read by the submitting authors (who may also
be anonymous), with an additional place to provide confi-
dential comments that the paper authors do not see. This
can be used to advise the editors about something very sen-
sitive – for example, that you suspect plagiarism or research
misconduct, or that you have some personal thoughts that
you need to keep private for some reason. Otherwise, any-
thing you have to say should be said transparently to the Au-
thors just as much as the Editors.
Many journals now make the identity of the reviewer
as well as the authors open (and not just to each other;
some journals also post reviewers’ comments online
alongside the final published article). But in any case, al-
ways imagine that your identity is known to the authors,
and afford respect and courtesies accordingly. In other
words, never hide behind anonymity (if that is the jour-
nal’s protocol) to write rude or ad hominem comments.
Don’t be late
Many authors wait anxiously for news of their paper from
the journal. It seems to take forever, and the delay is often
very costly for them – they cannot easily progress with a
second paper, they need the publication for promotion or a
grant application, and so on. The rate-limiting step can
sometimes be finding appropriate people who agree to re-
view the paper and then waiting for the reviewers’ reports
to be submitted. If you commit to doing the review, make
sure you include the ‘complete-by’ date in that commit-
ment. Many journals have elaborate reminder systems.
Additional delay is as discourteous as a rude comment.
Before hitting submit
We all have more to do than time to do it, and it can
sometimes be tempted to rush the completion of a
refereeing task. Check it for typographical and grammat-
ical errors (it is particularly galling for an author to be
criticized for typos from a review peppered with them),
as well as general sense.
Conclusions
The role of a reviewer comes with responsibility. The
contribution that peer review can make to ensuring that
published research is valid and clearly reported is often
influenced by the quality of the peer review itself. Per-
forming peer review of papers is an important contribu-
tion that every researcher needs to make, and it can be
rewarding for a variety of reasons – including that, by
reviewing papers, you learn to identify errors which you
may then be less likely to make yourself. Developing
solid skills in peer reviewing research papers is as im-
portant a skill as being able to write one.
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